1. Home
  2. BLDE vs SERA Comparison

BLDE vs SERA Comparison

Compare BLDE & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • SERA
  • Stock Information
  • Founded
  • BLDE 2014
  • SERA 2008
  • Country
  • BLDE United States
  • SERA United States
  • Employees
  • BLDE N/A
  • SERA N/A
  • Industry
  • BLDE Aerospace
  • SERA Precision Instruments
  • Sector
  • BLDE Consumer Discretionary
  • SERA Health Care
  • Exchange
  • BLDE Nasdaq
  • SERA Nasdaq
  • Market Cap
  • BLDE 276.7M
  • SERA 208.7M
  • IPO Year
  • BLDE N/A
  • SERA 2021
  • Fundamental
  • Price
  • BLDE $3.95
  • SERA $8.35
  • Analyst Decision
  • BLDE Buy
  • SERA
  • Analyst Count
  • BLDE 1
  • SERA 0
  • Target Price
  • BLDE $6.00
  • SERA N/A
  • AVG Volume (30 Days)
  • BLDE 1.6M
  • SERA 87.5K
  • Earning Date
  • BLDE 11-12-2024
  • SERA 11-06-2024
  • Dividend Yield
  • BLDE N/A
  • SERA N/A
  • EPS Growth
  • BLDE N/A
  • SERA N/A
  • EPS
  • BLDE N/A
  • SERA N/A
  • Revenue
  • BLDE $241,814,000.00
  • SERA $94,000.00
  • Revenue This Year
  • BLDE $11.34
  • SERA N/A
  • Revenue Next Year
  • BLDE $5.73
  • SERA $4,471.43
  • P/E Ratio
  • BLDE N/A
  • SERA N/A
  • Revenue Growth
  • BLDE 12.04
  • SERA N/A
  • 52 Week Low
  • BLDE $2.45
  • SERA $4.90
  • 52 Week High
  • BLDE $5.17
  • SERA $12.36
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 47.19
  • SERA 57.84
  • Support Level
  • BLDE $3.95
  • SERA $7.91
  • Resistance Level
  • BLDE $4.45
  • SERA $8.60
  • Average True Range (ATR)
  • BLDE 0.37
  • SERA 0.58
  • MACD
  • BLDE -0.08
  • SERA 0.07
  • Stochastic Oscillator
  • BLDE 11.45
  • SERA 67.96

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Share on Social Networks: